Insilico Medicine

IPO

Generative AI and Automation for Longevity and Sustainability

Public · Hong Kong, Hong Kong · Founded 2014 · $632.8M raised

Headquarters
Hong Kong
Employees
201–500
Founded
2014
Business Model
B2B
Total Funding
$632.8M
Last Round
$123.0M Series EMar 2026
Rounds
9
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Insilico Medicine develops breakthrough solutions using generative artificial intelligence to accelerate drug discovery and development for diseases like cancer, fibrosis, immunity, and CNS disorders. The company aims to extend healthy productive longevity by reducing time and cost in bringing life-saving medications to patients. Platforms include Chemistry42, Biology42, and Pharma.ai.

Summary

Insilico Medicine is an Artificial Intelligence company based in Hong Kong, Hong Kong, founded in 2014. It has raised $632.8M in total across 9 rounds, most recently a $123.0M Series E round in Mar 2026. Investors include Warburg Pincus, OrbiMed and F-Prime Capital.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Series ESeries EMar 2026
$123.0M

Sign up to see all 10 events

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Insilico Medicine on Indexed.vc
<a href="https://indexed.vc/companies/insilico-medicine"><img src="https://indexed.vc/api/badge/company/insilico-medicine" alt="Insilico Medicine on Indexed.vc" width="260" height="76" /></a>